We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$560M
AUM Growth
+$73.4M
Cap. Flow
+$17.4M
Cap. Flow %
3.11%
Top 10 Hldgs %
35.89%
Holding
404
New
56
Increased
149
Reduced
167
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 6.95%
2 Healthcare 3.72%
3 Financials 2.67%
4 Consumer Discretionary 2.34%
5 Communication Services 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSJK
401
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
-12,987
Closed -$303K
IMMU
402
DELISTED
Immunomedics Inc
IMMU
-44,550
Closed -$3.79M
HZNP
403
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-2,912
Closed -$226K
BSCK
404
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
-23,438
Closed -$497K

Similar funds

Calton & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Calton & Associates held 404 positions worth $560M, up 15% from $487M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Calton & Associates deployed $17.4M of net new capital in Q4 2020, opening 56 new positions and adding to 149 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Value ETF: 57,832 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $9.83M trimmed.

  • Calton & Associates's largest Q4 2020 buy was iShares S&P Small-Cap 600 Value ETF: 57,832 shares worth $4.7M.
  • Calton & Associates added most to iShares Core S&P Total US Stock Market ETF in Q4 2020, an estimated $11M increase.
  • Calton & Associates's biggest Q4 2020 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $9.83M.
  • Calton & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $3.79M.
  • Calton & Associates's ten largest holdings make up 36% of its $560M portfolio in Q4 2020.
  • Calton & Associates opened 56 new positions and closed 22 in Q4 2020.
  • Calton & Associates's portfolio value rose 15% quarter-over-quarter to $560M.

Based on Calton & Associates's 13F filing for Q4 2020, filed 25 Jan 2021.